Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fang-Lin Zhang
Observed name:
Fang‐Lin Zhang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Nanchang University,
Wuhan University of Technology,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0002-5728-0272
Observed ORCID:
0000-0002-5728-0272
OpenAlex ID:
A5056355334
FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression
2018
·
Rui Sun
, Hong-Yan Xie
, et al.
·
Cancer Research
·
105
Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer
2018
·
Fang-Lin Zhang
, Jin-Ling Cao
, et al.
·
Cancer Research
·
95
Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer
2022
·
Li Liao
, Yin-Ling Zhang
, et al.
·
Cancer Research
·
78
RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2
2019
·
Yin-Long Yang
, Ye Zhang
, et al.
·
Cell Death and Differentiation
·
65
PDF
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1
2024
·
Ling Deng
, Li Liao
, et al.
·
Science Advances
·
63
Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy
2022
·
Fang-Lin Zhang
, Da-Qiang Li
·
International Journal of Molecular Sciences
·
60
PDF
Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells
2019
·
Fan Yang
, Hong-Yan Xie
, et al.
·
Autophagy
·
59
USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells
2019
·
Qin Lu
, Fang‐Lin Zhang
, et al.
·
Cancer Medicine
·
43
PDF
HIF‐1α promotes the proliferation and migration of pulmonary arterial smooth muscle cells via activation of Cx43
2021
·
Xiao‐Jian Han
, Wei‐Fang Zhang
, et al.
·
Journal of Cellular and Molecular Medicine
·
34
PDF
MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression
2023
·
Ling Deng
, Li Liao
, et al.
·
Cancer Letters
·
30
Epigenetic silencing of RNF 144A expression in breast cancer cells through promoter hypermethylation and MBD 4
2018
·
Ye Zhang
, Yin‐Long Yang
, et al.
·
Cancer Medicine
·
18
PDF
Pregnancy‐specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF‐β/Smad signaling to drive breast cancer progression
2020
·
Ying‐Ying Liu
, Sa Zhang
, et al.
·
Clinical and Translational Medicine
·
16
PDF
Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
2024
·
Lisa Andriani
, Yun-Xiao Ling
, et al.
·
Cancer Letters
·
15
HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression
2022
·
Fan Yang
, Rui Sun
, et al.
·
Clinical and Translational Medicine
·
14
ETHE1 Accelerates Triple-Negative Breast Cancer Metastasis by Activating GCN2/eIF2α/ATF4 Signaling
2023
·
Shao-Ying Yang
, Li Liao
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
MYC/TET3‐Regulated TMEM65 Activates OXPHOS‐SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple‐Negative Breast Cancer
2025
·
Yin‐Ling Zhang
, Min‐Ying Huang
, et al.
·
Advanced Science
·
9
Inositol monophosphatase 1 ( IMPA1 ) promotes triple‐negative breast cancer progression through regulating mTOR pathway and EMT process
2022
·
Shao‐Ying Yang
, Yi‐Fan Xie
, et al.
·
Cancer Medicine
·
8
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer
2024
·
Min-Ying Huang
, Shu-Yuan Hu
, et al.
·
Cancer Research
·
7
Destabilization of microrchidia family CW‐type zinc finger 2 via the cyclin‐dependent kinase 1‐chaperone‐mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule‐targeting agents
2023
·
Shu‐Yuan Hu
, Jin‐Xian Qian
, et al.
·
Clinical and Translational Medicine
·
7
PDF
Kinesin-like protein KIFC2 stabilizes CDK4 to accelerate growth and confer resistance in HR+/HER2– breast cancer
2025
·
Shao-Ying Yang
, Ming-Liang Jin
, et al.
·
Journal of Clinical Investigation
·
6
PDF
Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression
2024
·
Si-Yu Chen
, Fang-Lin Zhang
, et al.
·
Cancer Letters
·
5
C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple‐negative breast cancer
2023
·
Li Liao
, Ling Deng
, et al.
·
Clinical and Translational Medicine
·
5
PDF
Secernin‐2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple‐Negative Breast Cancer
2025
·
Min‐Ying Huang
, Jia‐Yang Cai
, et al.
·
Advanced Science
·
3
Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1
2026
·
Yun-Xiao Ling
, Lisa Andriani
, et al.
·
Cell Death and Disease
·
1
PDF
Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer
2026
·
Jia-Yang Cai
, Min-Ying Huang
, et al.
·
Nature Communications
PDF
Show more works
View as search
Works count:
37
Citation count:
757
H-index:
14
I10-index:
15
Year
Topic
Type